Clinical Trials Directory

Trials / Unknown

UnknownNCT00433277

Autoimmunity in Retinitis Pigmentosa

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Semmelweis University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.

Conditions

Interventions

TypeNameDescription
DRUGtwice-daily dosage with 0.5% cyclosporine-A eyedrops

Timeline

First posted
2007-02-09
Last updated
2007-02-09

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT00433277. Inclusion in this directory is not an endorsement.